Cora Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Cora Therapeutics's estimated annual revenue is currently $310k per year.
- Cora Therapeutics's estimated revenue per employee is $77,500
Employee Data
- Cora Therapeutics has 4 Employees.
- Cora Therapeutics grew their employee count by 0% last year.
Cora Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.7M | 9 | -72% | $39.4M | N/A |
#2 | $0.9M | 11 | -83% | $23.8M | N/A |
#3 | $87.6M | 565 | 6% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $7.8M | 50 | -68% | N/A | N/A |
#6 | $13.5M | 87 | 30% | N/A | N/A |
#7 | $17.8M | 115 | -6% | N/A | N/A |
#8 | $0.9M | 11 | -39% | N/A | N/A |
#9 | $13.6M | 88 | -20% | $86M | N/A |
#10 | $20M | 129 | -12% | N/A | N/A |
What Is Cora Therapeutics?
Cora Therapeutics is a company dedicated to delivering and supporting innovative research-based wellness solutions for whole body health, led by Dr Kieran Murphy.\n\nDr. Murphy has lost colleagues to diseases that are linked to long-term occupational radiation exposure and, as a practicing physician himself, long recognized the need for better ways to counter radiation exposure. In 2011 he began developing an antioxidant formulation to help prevent cellular and mitochondrial damage from oxidative stress. The end result is Halo, the first product launched by Cora Therapeutics.
keywords:N/A
N/A
Total Funding
4
Number of Employees
$310k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Toronto
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.3M | 4 | -85% | N/A |
#2 | $0.5M | 4 | 0% | N/A |
#3 | $0.3M | 4 | 0% | N/A |
#4 | $0.3M | 4 | N/A | N/A |
#5 | $0.3M | 4 | N/A | N/A |